filmov
tv
Simplifying New Migraine Treatments: Gepants and Ditans - Spotlight on Migraine S2:Ep7
Показать описание
Join us for an information-packed episode where Dr. Stewart Tepper simplifies what you need to know about gepants and ditans. Describing this as the best time to be a migraine patient, Dr. Tepper explains the impact of these new treatments and breaks down their side effects, drug interactions, insurance barriers and more.
*The contents of this podcast are intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. The speaker does not recommend or endorse any specific course of treatment, products, procedures, opinions, or other information that may be mentioned. Reliance on any information provided by this content is solely at your own risk.
*The contents of this podcast are intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. The speaker does not recommend or endorse any specific course of treatment, products, procedures, opinions, or other information that may be mentioned. Reliance on any information provided by this content is solely at your own risk.
Simplifying New Migraine Treatments: Gepants and Ditans - Spotlight on Migraine S2:Ep7
How to integrate gepants into migraine clinical care
Gepants for Migraine Disease - Chapter 5: Episode 3 - Explainer Video Series
Acute Treatment of Migraine with Gepants: When You Need to Act Fast
Susan Hutchinson, MD: The Potential of the Gepant Class in Acute Migraine
Migraine: a new treatment landscape
CGRP & Gepants: What We Know and What to Expect
Development of Oral CGRP Molecule Inhibitors for Acute Migraine
Peter Goadbsy, MD, PhD, DSc: Differentiating Between CGRPs, Synthesizing the Gepants
The Role of CGRP as Targeted Treatment for Migraine - Module 2: Ubrogepant
ELYXYB, The Newest Acute Migraine Treatment
New Migraine Treatments | AMF
Christopher Gottschalk, MD: Long-Term Safety in Preventive Migraine Therapies
Upcoming treatments for migraine: zavegepant, rimegepant and atogepant
New Treatments for Migraine Headaches
The updated guidelines for treating migraines with CGRP-targeted monoclonal antibodies
Lasmiditan for Acute Migraine Treatment
Relivion Neuromodulation Device For Migraine Treatment
Dr Robert Boland-Freitas - what are CGRPs?
What's New in Migraine
New migraine medicine approved by FDA
Phase 3 study of lasmiditan for acute treatment of migraine
Exploring the Latest Evidence on New and Emerging Therapies for Migraine Prevention
New Migraine Medications: November 2020
Комментарии